BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TriLink BioTechnologies Enters into Distribution Agreement with Sigma-Aldrich Corporation (SIAL)


1/18/2012 3:34:58 PM

SAN DIEGO (January 18, 2012) - TriLink BioTechnologies Inc. (TriLink) announced that it has entered into a distribution agreement with Sigma-Aldrich to sell its CleanAmp™ dNTPs globally.

As an innovative approach to Hot Start PCR, TriLink's CleanAmp™ dNTPs are an ideal complement to Sigma-Aldrich's product and service offerings. In developing CleanAmp™, TriLink applied their expertise in modified nucleic acid chemistry to resolve common PCR problems, such as primer dimer formation and mis-priming. The latest advancement in CleanAmp™ dNTP chemistry allows improved amplicon yield in endpoint PCR and earlier Cq values in fast cycling real-time PCR.

"TriLink is very pleased to have its innovative Hot Start PCR technology, CleanAmp™ dNTPs added to the line of PCR reagents offered by Sigma. CleanAmp™ dNTPs are a great addition to Sigma's portfolio and Sigma's global distribution channels will undoubtedly get this novel technology into more hands," stated TriLink's President and CEO, Richard Hogrefe, Ph.D.

About TriLink

TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the research, diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services in ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit their web site at www.trilinkbiotech.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES